CD86 and cancer: Antigen-presenting molecules like MHC-I, MHC-II, co-inhibitory molecules (CTLA4), or co-stimulatory molecules (CD80, CD86) are crucial for presenting cancer antigens to T cells and triggering an immune reaction.